Welcome to Nutrition & Diabetes

Online * Open Access * Highest Quality Research

Nutrition & Diabetes is a peer-reviewed, online, open access journal bringing to the fore outstanding research in the areas of nutrition and chronic disease, including diabetes, from the molecular to the population level.

Nutrition & Diabetes recently received an Impact Factor of 3.534* - submit to Nutrition & Diabetes and benefit from:

  • Wide visibility for your research through open access publication
  • Online submission and prompt publication times
  • Global exposure through nature.com to a wide audience

Download our author instructions (PDF, 340kB) to find out more.

Volume 7,
July 2017

ISSN (online): 2044-4052

2016 Impact Factor 3.534*
54/138 Endocrinology & Metabolism
24/81 Nutrition & Dietetics

Richard Atkinson
Ian Macdonald
Manfred Müller

*2016 Journal Citation Reports® Science Edition (Clarivate Analytics, 2017)

Not to be missed

Don’t miss out on these recently trending articles

Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects
Extra virgin olive oil (EVOO) is a key component of the Mediterranean diet and seems to account for the protective effect against cardiovascular disease. This study reports the beneficial effect of EVOO on post-prandial glycemic and low-density lipoprotein-cholesterol (LDL-C) profile providing a novel insight into the mechanism potentially accounting for the antiatherosclerotic effect of such a diet.

Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans
This study shows that differences in colonic fermentation exist between lean and overweight or obese participants and that adiposity may be linked to gut microbiota and faecal short chain fatty acid (SCFA) concentrations in healthy humans. More in-depth studies looking at the metabolic fate of SCFA produced in lean and overweight or obese participants are needed in order to determine the role of SCFA in obesity.

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
SGLT2 inhibitors are a promising new class of antidiabetic drugs currently approved in Europe, the US and Japan. They allow weight-reducing and effective glycaemic control combined with a low risk of hypoglycaemia. The medication can be used in any stage of the disease independently of existing co-medications. This review covers the molecular mechanism of action, regulatory status, efficacy and safety of SGLT2 inhibitors with focus on canagliflozin.

A dietary intervention for chronic diabetic neuropathy pain: a randomized controlled pilot study
Diabetic neuropathy is a common and often debilitating condition for which available treatments are limited. This pilot study suggests the potential value of a plant-based diet intervention, including weekly support classes, for treating this painful complaint.


Nature Reviews Cardiology presents a poster on the effects of new antidiabetic drugs on cardiovascular health
This poster summarizes cardiovascular outcome trials of newly developed glucose-lowering agents. Some of these drugs have shown cardiovascular benefit that might have clinical importance in the management of type 2 diabetes mellitus.

Available to download free online: http://www.nature.com/nrcardio/posters/antidiabetics/index.html.

Thank you to our reviewers
We would like to thank all those who took the time to review for Nutrition & Diabetes in 2014. The journal could not exist without the knowledge and critical evaluation that our reviewers provide. Your generosity is much appreciated, and we hope your association with the journal continues in future. Please click here for the full list of reviewers.

100 articles now published
As of January 2014, Nutrition & Diabetes has now published 100 articles.

Extra navigation

18 August 2017

Sign up for e-alerts Web feed